What Every Woman Should Know about Cervical Cancer (eBook)
XLI, 527 Seiten
Springer Netherland (Verlag)
978-94-017-7560-1 (ISBN)
This book (an updated and extended edition) is about mobilizing women and health care policy makers and providers to unite their efforts in a single strategy for fighting cervical cancer worldwide. The objective of this strategy would be to reverse cervical cancer prevalence and mortality rates among all 2.4 billion women at risk and to achieve this goal within 10-15 years of implementation. Cervical Cancer Screening (Pap test, VIA, VILI, or HPV) failed to stop cervical cancer worldwide simply because many countries could not afford developing infrastructure necessary to carry on the global strategy, and because the outreach could not accomplish the targeted 51% of the population at risk. In 2015, there is still 600,000 women getting cervical cancer annually and 300,000 of them die. Every minute one woman gets cervical cancer and every 2 minutes one woman dies from this preventable disease.
In 21st Century the Information Technology (IT) Revolution has made substantial impact on medicine enabling remote points-of care, scattered around the world, to be e-connected with experts in distant medical centers and to obtain quality diagnosis and proper guidelines for curative therapy of early stages of cervical cancer. Low frequency of costly interventions needed makes IT-based screening financially and socially beneficial for mass screening.
This new Mobile Health technology with the Global Strategy for Fighting Cervical Cancer is subject to elaboration in our book as the new hope when old efforts have failed to stop the world 'epidemics' of this grave but preventable disease. The language is adapted for easy reading and understanding by professionals and lay-persons.
This book is intended for women at risk for cervical cancer, their health care providers, health insurance companies, government responsible for making health policy and healthcare industry because all of them have special role in the new Global Strategy elaborated in details in this book.
This book (anupdated and extended edition) is about mobilizing women and health care policymakers and providers to unite their efforts in a single strategy for fightingcervical cancer worldwide. The objective of this strategy would be to reversecervical cancer prevalence and mortality rates among all 2.4 billion women atrisk and to achieve this goal within 10-15 years of implementation. CervicalCancer Screening (Pap test, VIA, VILI, or HPV) failed to stop cervical cancerworldwide simply because many countries could not afford developinginfrastructure necessary to carry on the global strategy, and because theoutreach could not accomplish the targeted 51% of the population at risk. In2015, there is still 600,000 women getting cervical cancer annually and 300,000of them die. Every minute one woman gets cervical cancer and every 2 minutesone woman dies from this preventable disease.In 21st Centurythe Information Technology (IT) Revolution has made substantial impact onmedicine enabling remote points-of care, scattered around the world, to bee-connected with experts in distant medical centers and to obtain qualitydiagnosis and proper guidelines for curative therapy of early stages ofcervical cancer. Low frequency of costly interventions needed makes IT-basedscreening financially and socially beneficial for mass screening.This newMobile Health technology with the Global Strategy for Fighting Cervical Canceris subject to elaboration in our book as the new hope when old efforts havefailed to stop the world epidemics of this grave but preventable disease. Thelanguage is adapted for easy reading and understanding by professionals andlay-persons.This book isintended for women at risk for cervical cancer, their health care providers,health insurance companies, government responsible for making health policy andhealthcare industry because all of them have special role in the new GlobalStrategy elaboratedin details in this book.
PrelimsPROLOGUECHAPTER
1The
FEMALE REPRODUCTIVE SYSTEM IN HEALTH
AND DISEASE
1.1 Basic Anatomy of the Female Reproductive System1.1.1The
Ovaries1.1.2 Fallopian
Tubes1.1.3 The
Uterus1.1.4The Vagina1.1.5The Vulva
and the Perineum
1.2 Basic
Physiology of the Female Reproductive System1.2.1 Female
Hormones1.2.2 The
Menstrual Cycle1.2.3 Pregnancy1.2.4 Menopause 1.3. An Overview
of the Most Common Women’s Diseases1.3.1 Menstrual
Disorders1.3.2 Other
Disorders1.3.3 Common
Infections in Women1.3.4 Sexually
Transmitted Diseases 1.4
Tumors of the Female Genital System 1.4.1 Benign Tumors1. 4.2.
Malignant Tumors other than Cervical Cancer CHAPTER
2 CERVICAL
CANCER 2.1
About Cervical Cancer and Pre-carcinomatosis 2.1.1 Introduction2.12 Definition2.13 Interpretation 2.2
Epidemiology of Cervical Cancer 2.3
Prevention and Control of Cervical
Cancer 2.3.1 Risk Factors and Education to
Reduce Their Influence 2.3.2 Cancer Control: Cervical
Cancer/Pre-carcinomatosis Screening 2.3.3 Non-cytological based Cervical
Cancer Screening
2.3.4 Management of Women When
the Pap test result Returns2.3.5Biomarkers
and Cervical Cancer2.3.6Human
Papilloma Virus and Cervical Cancer 2.4 Diagnosis and Treatment of Cervical Cancer2.4.1 Diagnostic Methods 2.4.2 Staging System 2.4.3
Planning Therapy 2.4.4
Cervical Cancer Treatment 2.5 Prognosis of Cervical Cancer and How to improve
it CHAPTER
3 LIVING WITH CERVICAL CANCER 3.1 Cooping3.1.1
How to Cope When the Result is Abnormal Pap Test?3.1.2 The Diagnosis is Cervical Cancer3.1.3 Support fro Caregivers and Close Family in
Day-by-Day Coping with the Disease3.1.4 Support of Extended Family and Friends3.1.5 Support
Groups 3.2 Living with Cancer 3.2.1 Complementary and Alternative
Medicine3.2.2
Holistic View of Health and Wellness3.2.3
Which are other dimensions of Health
Described as a Holistic Health Model3.2.4
How we can
achieve A Higher Level of Wellness Across all Dimensions of Health?3.2.5
Understanding
the Mechanism of Stress3.2.6
Stress
Release Strategies3.2.7
An overview on Eating for Optimal Health in
Cancer Prevention and Cancer Prevention and Cervical Cancer 3.3
Stories from Real People 3.4
Survey on What Women Think About Pap Test 3.4.1 Background3.4.2 Identifying
the Problem3.4.3 Addressing the Problem3.4.4 Study Results and Analysis3.4.5 Conclusion CHAPTER
4 CERVICAL
CANCER SCREENING AFTER 2008 4.1.
CURRENT PRACTICES4.1.1 Afterward to the 2008 Edition: What we have predicted4.1.2 What happened with Pap test4.1.2.1
Dethroning classic Pap test4.1.2.2
Disappointment with the global outreach4.1.2.3
Failure
of alternatives to repeat the success of the Pap test in the US4.1.2.4
Attempt
to balance the screening cost with the
benefit obtained4.1.2.5
Search
for new ideas to reverse the increasing cancer trends worldwide4.1.2.6
Change
of the WHO strategy 4.1.3 Pap test now 4.1.4 Challenges to standard Pap test – An overview 4.1.5 Liquid - based cervical cytology. 4.1.6 HPV testing and immunization 4.1.7 Management of women after
Pap test 4.2
GUIDELINES 4.2.1 Overview on Guidelines 4.2.2 Individual Guidelines 4.2.2.1 ACOG 4.2.2.2 ASC 2015 4.2.2.3 ASCCP 4.2.2.4 USPSTF 4.2.2.5 WHO CHAPTER
5 GLOBAL
CERVICAL CANCER SCREENING 5.1 Worldwide Application of Cervical Cancer
Screening5.2 Cervical Cancer Statistics-world5.3 Gross Domestic Product per Capita5.4 Study Summary5.4.1 Examples5.4.1.1
US
India Symposium on Cervical Cancer5.4.1.2
India
Press Release 20155.4.1.3
Cervical
Cancer in China Press Release 2015 5.4.1.4 Republic of Serbia 5.4.2 Continents- World Summary 5.5.
Preliminary
Data Pilot Study 5.6 Examples from Individual countries CHAPTER 6 NEW STRATEGY and ITS GLOBAL APPLICATION 6.1 Executive Summary6.2 Global Cervical Cancer Screening6.2.1
Introduction6.2.1.1 Why New
Strategy6.2.1.2 Which
Strategy to Choose6.2.1.3 New
Strategy Applied for India6.2.1.4 Instead of Conclusion 6.3 MarkPap® Technology Platform 6.4 Social Impact: LMIC and Alleviation of
health disparity 6.5. Economic Impact - Cost Benefit6.5.1 Global Funding and Application of the New
Strategy 6.5.2 Global Benefit6.5.3 Socio-economic Advantage 6.6 Policy Change (India) CHAPTER 7 NEW TOOLS: MarkPap
Platform Technology Illustrated 7.1 MarkPap®
Platform Technology: MarkPap Illustrated7.1.1 MarkPap®Test 7.1.2 MarkPap® Reagent Kit with
Accessories 7.1.3 MarkPap® Specimen Collection
Kit™ 7.1.4
MarkPap® Telecytopathology ``````````7.1.5 MarkPap®
Digital (Tele -Pap)7.1.6 MarkPap®
Mobile 7.2 IT
Telehealth Center (ITTHC) 7.3 The New
Integrative Complex MEDYKO 7.3.1
Concept7.3.2
Letter7.3.3
Methods
Comparison 7.4 TEMPLATE
for Telecytopathology 7.5 Screen and
Treat with MarkPap 7.6 Telecytopathology
Protocol Chapter
8 REFERENCES 8.1 Ethics8.2 Literature
Cited8.3 Where
to Read More8.4 Index8.5 EPILOGUE CHAPTER
9 ANNEX 9.1
Brochures 9.1.1
MarkPap India, LLC. Fighting Cervical Cancer.
Brochure, 2012 9.1.2
MarkPap Pacific, LLC. Cervical Cancer in
China. Brochure. How we can help. 2013 9.2 Power Point Presentations 9.2.1
National Institute for Standards and
Technology (NIST).Lecture
on MarkPap Technology, 20149.2.2
Global Health Challenges: Is worldwide
cytological cervical screening possible? 2105 9.2.3MarkPap
Pacific presents: MarkPap® Technology, 2013 9.2.4 China Deal Overview. MarkPap Pacific, LLC, 2009 <9.2.5. MarkPap Pacific, LLC.
Opportunity in China, 2008 9.2.6MarkPap
India, LLC. Cervical Cancer. How we can help. 2012 9.2.7 BioSciCon, Inc. Special strategies for
fighting cervical cancer in India. 2015 9.2.8 BioSciCon, Inc. Fighting cervical cancer in
Azerbaijan, 2013 9.2.9 BioSciCon, Inc. MarkPap technology for prevention
cervical cancer in Africa, 2015 9.2.10 Global Academy for Women’s Health. Cervical
Cancer: Past, present and future.
Invited lecture, 2013. Northern Virginia Community College, NOVA, Annandale, VA Chapter
10 MEDIA 10.1 WHO Book 2013 10. 2 Molecular Kinetics. Video. Presentation at the
NIH Symposium on Single Cell Analysis NIH, Bethesda MD, 2013 10. 3 Single Cell Analysis Enzyme Kinetics. Short
version, Video, 2013 10. 4
Telemedicine in Cervical Cancer Screening. Video, Johns Hopkins University,
Rockville, MD, 2012 10.5 Cervical Cancer Screening in India. PPP
presentation with sound, 2013 10.6 Molecular Kinetics and Drug Testing. Slide
Show, NIH, Bethesda, MD, 2012 10.7 Media Content
| Erscheint lt. Verlag | 19.12.2016 |
|---|---|
| Zusatzinfo | XLI, 527 p. 466 illus., 281 illus. in color. |
| Verlagsort | Dordrecht |
| Sprache | englisch |
| Themenwelt | Sachbuch/Ratgeber ► Gesundheit / Leben / Psychologie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Allgemeinmedizin | |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Gynäkologie / Geburtshilfe | |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
| Medizin / Pharmazie ► Studium | |
| Schlagworte | anatomy • cancer prevention • Diagnosis • Physiology • prevention • Treatment |
| ISBN-10 | 94-017-7560-5 / 9401775605 |
| ISBN-13 | 978-94-017-7560-1 / 9789401775601 |
| Haben Sie eine Frage zum Produkt? |
PDF (Wasserzeichen)Größe: 26,9 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
